171 related articles for article (PubMed ID: 12496253)
61. The interaction of factor XIa with activated platelets but not endothelial cells promotes the activation of factor IX in the consolidation phase of blood coagulation.
Baird TR; Walsh PN
J Biol Chem; 2002 Oct; 277(41):38462-7. PubMed ID: 12167623
[TBL] [Abstract][Full Text] [Related]
62. The tissue factor region that interacts with substrates factor IX and Factor X.
Kirchhofer D; Lipari MT; Moran P; Eigenbrot C; Kelley RF
Biochemistry; 2000 Jun; 39(25):7380-7. PubMed ID: 10858285
[TBL] [Abstract][Full Text] [Related]
63. Replacing the first epidermal growth factor-like domain of factor IX with that of factor VII enhances activity in vitro and in canine hemophilia B.
Chang JY; Monroe DM; Stafford DW; Brinkhous KM; Roberts HR
J Clin Invest; 1997 Aug; 100(4):886-92. PubMed ID: 9259588
[TBL] [Abstract][Full Text] [Related]
64. An ordered sequential mechanism for Factor IX and Factor IXa binding to platelet receptors in the assembly of the Factor X-activating complex.
Yang X; Walsh PN
Biochem J; 2005 Aug; 390(Pt 1):157-67. PubMed ID: 15755260
[TBL] [Abstract][Full Text] [Related]
65. Functional characterization of platelet-bound factor XIa: retention of factor XIa activity on the platelet surface.
Walsh PN; Sinha D; Koshy A; Seaman FS; Bradford H
Blood; 1986 Jul; 68(1):225-30. PubMed ID: 3487355
[TBL] [Abstract][Full Text] [Related]
66. Localization of a calcium-dependent epitope to the amino terminal region of the Gla domain of human factor IX.
Cheung WF; Stafford DW; Sugo T
Thromb Res; 1996 Jan; 81(1):65-73. PubMed ID: 8747521
[TBL] [Abstract][Full Text] [Related]
67. Crystal structure of Mg2+- and Ca2+-bound Gla domain of factor IX complexed with binding protein.
Shikamoto Y; Morita T; Fujimoto Z; Mizuno H
J Biol Chem; 2003 Jun; 278(26):24090-4. PubMed ID: 12695512
[TBL] [Abstract][Full Text] [Related]
68. High-affinity calcium-binding site in the gama-carboxyglutamic acid domain of bovine factor VII.
Inoue K; Shimada H; Ueba J; Enomoto S; Tanaka-Saisaka Y; Kubota T; Koyama M; Morita T
Biochemistry; 1996 Oct; 35(43):13826-32. PubMed ID: 8901525
[TBL] [Abstract][Full Text] [Related]
69. Isolation and functional characterization of the active light chain of activated human blood coagulation factor XI.
van der Graaf F; Greengard JS; Bouma BN; Kerbiriou DM; Griffin JH
J Biol Chem; 1983 Aug; 258(16):9669-75. PubMed ID: 6604052
[TBL] [Abstract][Full Text] [Related]
70. Zymogen factor IX potentiates factor IXa-catalyzed factor X activation.
London FS; Walsh PN
Biochemistry; 2000 Aug; 39(32):9850-8. PubMed ID: 10933803
[TBL] [Abstract][Full Text] [Related]
71. Functional characterization of human blood coagulation factor XIa using hybridoma antibodies.
Sinha D; Koshy A; Seaman FS; Walsh PN
J Biol Chem; 1985 Sep; 260(19):10714-9. PubMed ID: 3875611
[TBL] [Abstract][Full Text] [Related]
72. Interaction of factor IXa with factor VIIIa. Effects of protease domain Ca2+ binding site, proteolysis in the autolysis loop, phospholipid, and factor X.
Mathur A; Zhong D; Sabharwal AK; Smith KJ; Bajaj SP
J Biol Chem; 1997 Sep; 272(37):23418-26. PubMed ID: 9287357
[TBL] [Abstract][Full Text] [Related]
73. Monoclonal antibody (VII-M31) to bovine factor VII: a specific epitope in the gamma-carboxyglutamic acid domain.
Higashi S; Kawabata S; Nishimura H; Funasaki H; Ohyama S; Miyamoto S; Funatsu A; Iwanaga S
J Biochem; 1990 Oct; 108(4):654-62. PubMed ID: 1705545
[TBL] [Abstract][Full Text] [Related]
74. Identification and purification of vitamin K-dependent proteins and peptides with monoclonal antibodies specific for gamma -carboxyglutamyl (Gla) residues.
Brown MA; Stenberg LM; Persson U; Stenflo J
J Biol Chem; 2000 Jun; 275(26):19795-802. PubMed ID: 10779512
[TBL] [Abstract][Full Text] [Related]
75. The binding of human factor IX to endothelial cells is mediated by residues 3-11.
Cheung WF; Hamaguchi N; Smith KJ; Stafford DW
J Biol Chem; 1992 Oct; 267(29):20529-31. PubMed ID: 1400370
[TBL] [Abstract][Full Text] [Related]
76. Factor IX Kawachinagano: impaired function of the Gla-domain caused by attached propeptide region due to substitution of arginine by glutamine at position -4.
Sugimoto M; Miyata T; Kawabata S; Yoshioka A; Fukui H; Iwanaga S
Br J Haematol; 1989 Jun; 72(2):216-21. PubMed ID: 2757966
[TBL] [Abstract][Full Text] [Related]
77. Comparison of the Ca2+ binding properties of the gamma-carboxyglutamic acid-containing module of protein Z in the intact protein and in N-terminal fragments.
Persson E; Stenflo J
FEBS Lett; 1992 Dec; 314(1):5-9. PubMed ID: 1451804
[TBL] [Abstract][Full Text] [Related]
78. Inhibition of prothrombin activation by factor X and factor IX Gla-peptides.
Wildgoose P; Kisiel W
Biochem Biophys Res Commun; 1988 May; 152(3):1207-12. PubMed ID: 3377773
[TBL] [Abstract][Full Text] [Related]
79. Redetermination of the rate-limiting step in the activation of factor IX by factor XIa and by factor VIIa/tissue factor. Explanation for different electrophoretic radioactivity profiles obtained on activation of 3H- and 125I-labeled factor IX.
Bajaj SP; Rapaport SI; Russell WA
Biochemistry; 1983 Aug; 22(17):4047-53. PubMed ID: 6604546
[No Abstract] [Full Text] [Related]
80. The propeptides of human protein C, factor VII, and factor IX are exchangeable with regard to directing gamma-carboxylation of these proteins.
Geng JP; Castellino FJ
Thromb Haemost; 1996 Aug; 76(2):205-7. PubMed ID: 8865532
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
